EpiPen maker Mylan to pay $465M to settle claims it overbilled Medicaid
Friday, October 7, 2016 - 19:31
in Mathematics & Economics
Doug G. WareCANONSBURG, Pa., Oct. 7 (UPI) -- Embattled pharma company Mylan agreed Friday to pay nearly a half-million dollars to settle claims it overbilled Medicaid for its life-saving EpiPen product.